Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
Abstract Knowledge of the excess risk posed by specific cardiovascular syndromes could
help in the development of strategies to reduce premature mortality among patients with
chronic kidney disease (CKD). The rates of atherosclerotic vascular disease, congestive
heart failure, renal replacement therapy, and death were compared in a 5% sample of the
United States Medicare population in 1998 and 1999 (n= 1,091,201). Patients were divided
into the following groups: 1, no diabetes, no CKD (79.7%); 2, diabetes, no CKD (16.5%); 3 …
help in the development of strategies to reduce premature mortality among patients with
chronic kidney disease (CKD). The rates of atherosclerotic vascular disease, congestive
heart failure, renal replacement therapy, and death were compared in a 5% sample of the
United States Medicare population in 1998 and 1999 (n= 1,091,201). Patients were divided
into the following groups: 1, no diabetes, no CKD (79.7%); 2, diabetes, no CKD (16.5%); 3 …